3rd Quarter - Report

DB3, LLC (FKA THE DASCHLE GROUP) for VALISURE

Period 3rd Quarter 2024 Filed Oct 21, 2024 Signed by Niki Carelli

Official filing
Firm
DB3, LLC (FKA THE DASCHLE GROUP)
Client
VALISURE
Income
$50,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to pharmaceutical safety and efficacy.

LobbyistCovered position, as disclosed
NICOLE CARELLI —

Contacted: Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; SENATE

Defense DEF

Issues related to pharmaceutical safety and efficacy, generally; FY25 DoD appropriations, issues related to pharmaceutical safety and efficacy.

LobbyistCovered position, as disclosed
NICOLE CARELLI —

Contacted: Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; SENATE

Veterans VET

Issues related to pharmaceutical safety and efficacy, generally; FY25 Milcon-VA appropriations, issues related to pharmaceutical safety and efficacy.

LobbyistCovered position, as disclosed
NICOLE CARELLI —

Contacted: HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.